• Title/Summary/Keyword: altertoxin-I

Search Result 3, Processing Time 0.019 seconds

Distribution of Mycotoxin-Producing Isolates in the Genus Alternaria (Alternaria속 균에 있어서 진균독소 생성균의 분포)

  • 이향범;유승헌
    • Korean Journal Plant Pathology
    • /
    • v.11 no.2
    • /
    • pp.151-157
    • /
    • 1995
  • 국내에서 분리한 20종의 Alternaria 277개 균주를 사용하여 Alternaria 진균소독인 altenuene(ALT), altertoxin-I(ATX-I) 및 tenuazonic acid(TA)의 in vitro에서의 생성능과 그 분포를 조사하였다. 각 사용균주를 200g의 살균된 쌀배지에 접종하여 $25^{\circ}C$에서 3주간 배양하였다. Alternaria 배양체들을 methanol로 추출하고 용매분획과 TLC 및 HPLC분석을 통하여 순화하였다. A. alternata와 그와 형태적으로 유사한 A. kikuchiana, A. longipes 및 A. mail는 비록 종간 및 종내의 균주간에 생성량의 차이는 매우 다양하였지만 TA를 비롯한 5종의 진균독소를 모두 생성하였다. A sesami와 A. sesamicola는 4종의 진균독소(AOH, AME, ALT, ATX-I)를 생성하였고 A. cucumerina, A. dauci, A. macrospora, A. porri, A. solani, A. tagetica와 A. zinniae와 같은 대형분생포자와 긴 beak를 형성하는 7종의 Alternaria균들은 AOH와 AME만을 생성하였다. A. brassicicola, A. helianthi, A. panax, A. radicina 및 A. raphani등 5종의 Alternaria는 5종의 진균 독소를 모두 생성하지 않았다.

  • PDF

Incidence of Altermaria Species in Red Pepper and Sesame from Korea and Their Ability to Produce Mycotoxins (한국산 고추와 참깨에 발생하는 Alternaria의 종류와 이들의 진균독소 생성능력)

  • 이향범;유승헌
    • Korean Journal Plant Pathology
    • /
    • v.11 no.1
    • /
    • pp.1-8
    • /
    • 1995
  • Alternaria alternata and A. solani were identified from 130 Alternaria isolates obtained from red pepper fruits, and three species including A. alternata, A. sesami and A. sesamicola were detected from 150 isolates from sesame seeds. Among the 4 Alternaria species, A. alternata was the predominant fungus from both plants, having incidence of 95.4% in red pepper and 56.0% in sesame. Of the total 280 isolates, cultures on autoclaved rice of 75 isolates were tested for toxicity to 21-day-old virgin female rats. Out of 50 isolates of A. alternata, 17 were lethal to rats, inducing congestion and hemorrhage of stomach and intestine and kidney enlargement, and 8 caused lack of weight gain or weight loss. The other 25 isolates of A. alternat and all the isolates of A. sesami, A. sesamicola and A. solani, showed no significant indication of toxicity. Production of mycotoxins in the rice cultures of the above 75 isolates belonging to 4 species was analyzed. Alternaria cultures were extracted with methanol and purified by using solvent partition, thin-layer chromatography, and high performance liquid chromatography. Of the four species tested, all produced alternariol (AOH) and alternariol monomethyl ether (AME), three (A. alternata, A. sesami and A. sesamicola) produced alternuene (ALT) and altertoxin-I (ATX-I), and only A. alternata produced tenuazonic acid (TA). TA was produced by all of the highly toxic (lethal to rats) isolates of A. alternata, but not by any nontoxic isolates.

  • PDF

Potent Selective Inhibition of Monoamine Oxidase A by Alternariol Monomethyl Ether Isolated from Alternaria brassicae

  • Lee, Hyun Woo;Kim, Yeon Ji;Nam, Sang-Jip;Kim, Hoon
    • Journal of Microbiology and Biotechnology
    • /
    • v.27 no.2
    • /
    • pp.316-320
    • /
    • 2017
  • Alternariol monomethyl ether (AME), a dibenzopyrone derivative, was isolated from Alternaria brassicae along with altertoxin II (ATX-II). The compounds were tested for the inhibitory activity of monoamine oxidase (MAO), which catalyzes neurotransmitting monoamines. AME was found to be a highly potent and selective inhibitor of human MAO-A with an $IC_{50}$ value of $1.71{\mu}M$; however, it was found to be ineffective for MAO-B inhibition. ATX-II was not effective for the inhibition of either MAO-A or MAO-B. The inhibition of MAO-A using AME was apparently instantaneous. MAO-A activity was almost completely recovered after the dilution of the inhibited enzyme with an excess amount of AME, suggesting AME is a reversible inhibitor. AME showed mixed inhibition for MAO-A in Lineweaver-Burk plots with a $K_i$ value of $0.34{\mu}M$. The findings of this study suggest that microbial metabolites and dibenzopyrone could be potent MAO inhibitors. In addition, AME could be a useful lead compound for developing reversible MAO-A inhibitors to treat depression, Parkinson's disease, and Alzheimer's disease.